Distribution of cyclooxygenase isoforms in murine chronic granulomatous inflammation. Implications for future anti‐inflammatory therapy

The Journal of Pathology

Volumn 176, Issue 4, 1995, Pages 413-420

  Appleton, Ian ^a   Tomlinson, Annette ^a   Mitchell, Jane A ^a   Willoughby, Derek A ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

chronic inflammation; cyclooxygenase

Indexed keywords

EID: 0029347138     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.1711760413     Document Type: Article

References (53)

1. Inflammation and the mechanisms of action of anti‐inflammatory drugs
2. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin‐like drugs
3. Inhibition of prostaglandin biosynthesis
4. Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa
5. Primary structure of prostaglandin G/H synthase from sheep vesicular gland determined from the complementary DNA sequence
6. Isolation and characterization of the complementary DNA for sheep seminal vesicle prostaglandin endoperoxide synthase (cyclooxygenase)
7. The aspirin and heme‐binding sites of ovine and murine prostaglandin endoperoxide synthase
8. Cloning of human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzyme
9. Expression of a mitogen‐responsive gene encoding prostaglandin synthase is regulated by mRNA splicing
10. TIS10, a phorbol ester tumor promoter‐inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue
11. Mitogen‐inducible prostaglandin G/H synthase: a new target for nonsteroidal and antiinflammatory drugs
12. Selectively of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygeanse
13. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding
14. Arachidonic acid metabolism
15. Inducible isoforms of cyclooxygenase and nitric oxide synthase in inflammation
16. In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis
17. Localization of enzymes responsible for prostagladin formation
18. Altered arachidonic acid metabolism during differentiation of the human monoblastoid cell line U937
19. Expression of a mitogen‐inducible cyclooxygenase in brain neurones: regulation by synaptic activity and glucocorticoids
20. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxidases
21. 2 (prostacyclin) by cultured human and bovine endothelial cells
22. 2 is not a major metabolite of arachidonic acid in cultured endothelial cells from human foreskin microvessels
23. Arachidonic acid metabolism in polymor‐phonuclear leukocytes: unstable intermediate in the formation of dihydroxy acids
24. Leukotriene B: a potential mediator of inflammation
25. 2 generation after activation of rat and human mast cells with anti‐IgE
26. Prostaglandin endoperoxidase synthase: regulation of enzyme expression
27. 4 during experimental inflammation
28. Kinin‐induced prostagladin synthesis by renal papillary collecting tubule cells
29. 2 activation in rabbit platelets
30. Regulation of vasopressin action by prostagladins: evidence for prostaglandin synthesis in the rabbit cortical collecting tubules
31. Angiotensin II stimulation of prostaglandin production in cultured human vascular endothelium
32. Stimulation of endothelial cell prostaglandin production by thrombin, trypsin and the ionophore A23187
33. Regulation of prostaglandin H synthase mRNA levels and prostaglandin biosynthesis by platelet‐derived growth factor
34. Exaggerated human prostaglandin biosynthesis mediated by monocytes: role of monokines and interleukin‐1
35. Restoration of prostacyclin synthase in vascular smooth muscle cells after aspirin treatment: regualtion by epidermal growth factor
36. 2 by rheumatoid arthritis synovial cells in culture
37. Analytical procedures for a cryptic messenger RNA that mediates translational control of prostaglandin synthase by glucocorticoids
38. Tumor necrosis factor causes amplification of arachidonic acid metabolism in response to interleukin 1, bradykinin and other agonists
39. Temporal and spatial immunolocalization of cytokines in murine chronic granulomatous tissue. Implications for their role in tissue development and repair processes
40. Expression of mRNA for cyclooxygenase‐1 and cyclooxygenase‐2 in human tissues
41. Prostagladins as mediators of inflammation
42. The role of arachidonic acid oxygenation products in pain and inflammation
43. Control of lymphokine secretion by prostaglandins
44. 2‐dependent induction of granulocyte macrophage colony stimulating factor secretion by cloned murine helper T cells
45. Cyclooxygenase inhibition enhances rat interleukin 1β‐induced growth of mesangial cells in culture
46. Prostaglandins antagonize fibroblast proliferation stimulated by tumour necrosis factor
47. 2
48. 2 on human lymphocyte transformation in the presence and absence of inhibitors of prostaglandin biosynthesis
49. 2 on adjuvant arthritis
50. Suppression of acute and chronic inflammation in adrenalectomized rats by pharmacological amounts of prostaglandins
51. 1
52. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation
53. Inhibition of polymorphonuclear leukocyte adhesion by prostacyclin